Cutting-Edge Research for Global Health
At Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), microbiologists, virologists, and other scientists focus on the increasing incidence of emerging infectious diseases. Many of these pathogens pose the threat of causing large scale epidemics or global pandemics. The goal of the NEIDL is to predict their appearance, detect, study, and respond to them in a timely manner. Because of the NEIDL’s extraordinary biocontainment capabilities, researchers have been able to work safely with a variety of live pathogens including COVID-19, HIV/AIDS, Ebola/Marburg, Zika, Yellow Fever, among others. Understanding basic molecular aspects of a pathogen, the interplay of the pathogen with its host, transmission dynamics, and clinical manifestations are all essential for the development of better diagnostics and safe, effective therapeutics and vaccines for us to treat, or even better, be able to prevent these diseases.
In the News
-
Novel compound protects against infection by virus that causes COVID-19, preliminary studies show.
Original article from Dana-farber newsroom. Posted date January 5, 2024...
-
Virology, Immunology & Microbiology Professor Robert Davey awarded $3.3M per year for five years.
The NIH National Institute of Allergies and Infectious Diseases awarded...
-
It’s good to feel bad after your COVID shot
New research suggests that the worse your symptoms are after...